Compare · head to head
InspireMD vs Lexicon Pharmaceuticals
Lexicon Pharmaceuticals ranks higher overall — 360 rank 28 vs 25.
Lexicon Pharmaceuticals leads on Quality (43 vs 16). InspireMD leads on Safety (61 vs 32). The two are close on Growth and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Pharmaceuticals |
| Size | Small | Small |
| ISIN | US45779A8466 | US5288723027 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 25 | 28 |
| Value | 47 | NR |
| Quality | 16 | 43 |
| Growth | 41 | 45 |
| Safety | 61 | 32 |
| Sentiment | 58 | 57 |
| Quality details | ||
| Profitability | 14 | 35 |
| Cash Truth | 19 | NR |
InspireMD vs Rigel PharmaceuticalsInspireMD vs NateraInspireMD vs Kestra Medical TechnologiesInspireMD vs SANUWAVE HealthAdd a third stock →
Full analyses: InspireMD · Lexicon Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100